RELIABLE BIOPHARMACEUTICAL CORPORATION

Company Information

Company Name
RELIABLE BIOPHARMACEUTICAL CORPORATION
Address
RELIABLE BIOPHARMACEUTICAL CORP.
BOX 2517, 1945 WALTON RD
ST. LOUIS, MO, 63114
Phone
1 314-429-7700
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$350,000.00
6
SBIR Phase II
$955,749.00
2
STTR Phase I
$134,076.00
1
Chart code to be here

Award List

  1. ISOLATION OF BULK DEOXYNUCLEOSIDES FOR AIDS DRUGS

    Amount: $368,318.00

    SEVERAL EXPERIMENTAL ANTI-VIRAL AIDS DRUGS (AZT, DDC, DDA) ARE BASED ON CHEMICALLY MODIFIED DEOXYNUCLEOSIDES. THESE DEOXYNUCLEOSIDE DERIVATIVES ARE MADE FROM RIBONUCLEOSIDES DUE TO THE UNAVAILABILITY ...

    SBIR Phase II 1989 Department of Health and Human Services
  2. SYNTHESIS AND TESTING OF A NEW CLASS OF HEPARINOIDS

    Amount: $50,000.00

    THE GOAL OF THIS PROJECT IS TO DEVELOP A THERAPEUTIC AGENT WHICH WOULD REPLACE HEPARIN. ALTHOUGH HEPARIN IS THE BEST DRUG FOR TREATMENT OF THROMBOEMBOLIC DISEASE, IT IS UNSTABLE IF ADMINISTERED ORALLY ...

    SBIR Phase I 1991 Department of Health and Human Services
  3. SYNTHESIS AND TESTING OF ANTIBIOTIC ANTISENSE CONJUGATES

    Amount: $50,000.00

    THE MAJOR GOAL OF THIS PROJECT IS TO PRODUCE ANTISENSE-OLIGODEOXYNUCLEOTIDES THAT WILL READILY BE TAKEN UP BY TARGET CELLS. TO ACCOMPLISH THIS, WE WILL ATTACH ANTIBIOTICS TO ANTISENSE-OLIGODEOXYNUCLEO ...

    SBIR Phase I 1992 Department of Health and Human Services
  4. Regulators of Fibroblast Growth Factor Activity

    Amount: $50,000.00

    TELEPHONE NUMBER: (314) 429-7700 AWARDEE NUMBER: 1 R43 CA61390-01 The overall objective is to develop polysulfated carbohydrate derivatives that will inhibit the action of fibroblast growth factors (F ...

    SBIR Phase I 1993 Department of Health and Human Services
  5. Synthesis of Oxidant-Free Potassium Lactobionate

    Amount: $50,000.00

    The overall objective is to develop a process to produce lactobionic acid that is free of oxidizing components. Lactobionic acid is an essential component of perfusion solutions used to preserve organ ...

    SBIR Phase I 1993 Department of Health and Human Services
  6. OLIGONUCLEOTIDES AS PRODRUGS FOR ANTICANCER DRUGS

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The overall objected is to develop an easy controlled method of delivery for anticancer nucleoside drugs [cytarabine (araC); cladribine] in their polymeric form as ...

    SBIR Phase I 2002 Department of Health and Human Services
  7. NEW INOTROPIC AGENTS FOR THE TREATMENT OF HEART FAILURE

    Amount: $134,076.00

    DESCRIPTION (provided by applicant): The goal of the project is to develop new positive inotropes, represented by specifically modified AMP molecules. All of the currently available positive inotropic ...

    STTR Phase I 2002 Department of Health and Human Services
  8. Synthesis and testing of a new class of heparinoids

    Amount: $587,431.00

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  9. ISOLATION OF BULK DEOXYNUCLEOSIDES FOR AIDS DRUGS

    Amount: $50,000.00

    N/A

    SBIR Phase I 1988 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government